The Siemens subsidiary is growing faster than analysts expected.
(Photo: Reuters)
Munich After a good start to the new fiscal year, optimism is growing at Siemens Healthineers. “The high demand for our antigen rapid tests allows us to raise our outlook for the year as a whole,” said CEO Bernd Montag on Thursday.
In the first quarter of 2021/22 (as of the end of September), the medical technology provider increased sales by 9.5 percent to almost 5.1 billion euros compared to the same period last year. The adjusted operating result (EBIT) improved by a good fifth to 898 million euros. This corresponded to a margin of 17.8 percent.
This also exceeded the expectations of analysts. On average, they had expected sales of EUR 4.9 billion and an adjusted operating result of EUR 829 million.
For the year as a whole, the Siemens offshoot wants to take in around 700 million euros with quick tests. The company had previously expected demand to subside and only 200 million euros.
Top jobs of the day
Find the best jobs now and
be notified by email.